The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?

The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?

The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed warning on antidepressants regarding the risk of suicidality in young adults still represents a matter of controversy. The FDA warning was grounded on industry-sponsored trials carried one decade ago...

Повний опис

Бібліографічні деталі
Автори: Michele Fornaro, Annalisa Anastasia, Alessandro Valchera, Alessandro Carano, Laura Orsolini, Federica Vellante, Gabriella Rapini, Luigi Olivieri, Serena Di Natale, Giampaolo Perna, Giovanni Martinotti, Massimo Di Giannantonio, Domenico De Berardis
Формат: Стаття
Мова:English
Опубліковано: Frontiers Media S.A. 2019-05-01
Серія:Frontiers in Psychiatry
Предмети:
FDA
antidepressant
suicide
“black box” warning
Major depression (MDD)
Bipolar Disorder
Онлайн доступ:https://www.frontiersin.org/article/10.3389/fpsyt.2019.00294/full

Інтернет

https://www.frontiersin.org/article/10.3389/fpsyt.2019.00294/full

Схожі ресурси